This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Witte, D. P. Articles by Harmony, J. A. Search for Related Content PubMed PubMed Citation Articles by Witte, D. P. Articles by Harmony, J. A.

American Journal of Pathology, Vol 143, 763-773, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions

DP Witte, BJ Aronow, ML Stauderman, WD Stuart, MA Clay, RA Gruppo, SH Jenkins and JA Harmony
Department of Pathology, Children's Hospital Medical Center, Cincinnati, OH 45229.

Apolipoprotein J (apoJ) is an abundant glycoprotein in many biological fluids, and its constitutive high level synthesis is characteristic of many epithelial cells exposed to harsh fluids such as urine, bile, and gastric secretions. In addition, dramatic induction of apoJ occurs in cells surrounding several kinds of pathological lesions. Because platelets and circulating inflammatory cells represent critical elements in numerous pathological processes, we evaluated bone marrow cells for the presence of apoJ. Based upon messenger RNA in situ hybridization and immunofluorescent protein detection, high-level apoJ gene expression and protein accumulation occurred exclusively in mature megakaryocytes. Our results indicate that apoJ is stored in platelet granules and is released into extracellular fluid following platelet activation. Because atheromatous plaque development involves platelet aggregation and activation, we looked for and found abundant apoJ protein in advanced human atheromatous lesions. Thus, platelet sequestration and activation may lead to the rapid deployment of apoJ into sites of vascular injury. We hypothesize that platelet-derived apoJ participates in both short-term wound repair processes and chronic pathogenic processes at vascular interfaces.

This article has been cited by other articles:

				J. J Yerbury, S. Poon, S. Meehan, B. Thompson, J. R. Kumita, C. M. Dobson, and M. R. Wilson The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures FASEB J, August 1, 2007; 21(10): 2312 - 2322. [Abstract] [Full Text] [PDF]

				A. Chait, C. Y. Han, J. F. Oram, and J. W. Heinecke Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J. Lipid Res., March 1, 2005; 46(3): 389 - 403. [Abstract] [Full Text] [PDF]

				A. Orlandi, S. Pucci, A. Ciucci, F. Pichiorri, A. Ferlosio, and L. G. Spagnoli Modulation of Clusterin Isoforms Is Associated With All-Trans Retinoic Acid-Induced Proliferative Arrest and Apoptosis of Intimal Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 348 - 353. [Abstract] [Full Text] [PDF]

				K. A. Hess, S. E. Waltz, E. L. Chan, and S. J.F. Degen Receptor Tyrosine Kinase Ron Is Expressed in Mouse Reproductive Tissues During Embryo Implantation and Is Important in Trophoblast Cell Function Biol Reprod, April 1, 2003; 68(4): 1267 - 1275. [Abstract] [Full Text] [PDF]

				W. Y. Sun, D. P. Witte, J. L. Degen, M. C. Colbert, M. C. Burkart, K. Holmback, Q. Xiao, T. H. Bugge, and S. J. F. Degen Prothrombin deficiency results in embryonic and neonatal lethality in mice PNAS, June 23, 1998; 95(13): 7597 - 7602. [Abstract] [Full Text] [PDF]

				Y. Ishikawa, Y. Akasaka, T. Ishii, K. Komiyama, S. Masuda, N. Asuwa, N.-H. Choi-Miura, and M. Tomita Distribution and Synthesis of Apolipoprotein J in the Atherosclerotic Aorta Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 665 - 672. [Abstract] [Full Text] [PDF]

				T. H. Bugge, K. W. Kombrinck, Q. Xiao, K. Holmback, C. C. Daugherty, D. P. Witte, and J. L. Degen Growth and Dissemination of Lewis Lung Carcinoma in Plasminogen-Deficient Mice Blood, December 1, 1997; 90(11): 4522 - 4531. [Abstract] [Full Text] [PDF]

				Q. Xiao, M. J. S. Danton, D. P. Witte, M. C. Kowala, M. T. Valentine, T. H. Bugge, and J. L. Degen Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis PNAS, September 16, 1997; 94(19): 10335 - 10340. [Abstract] [Full Text] [PDF]

				B. Mackness, R. Hunt, P. N. Durrington, and M. I. Mackness Increased Immunolocalization of Paraoxonase, Clusterin, and Apolipoprotein A-I in the Human Artery Wall With the Progression of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1233 - 1238. [Abstract] [Full Text]